Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 7Gastrointestinal 3Dermatologic 3Sarcoma 2Genitourinary 2Breast 2Tumor-Agnostic 1Plasma cell 1

Conditions

Pancreatic Neoplasms 2Chemotherapy;Advanced Gastric Cancer;Cisplatin;Disulfiram 1

Interventions

Oxaliplatin 1409Fluorouracil 1298Capecitabine 1085Gemcitabine 1042Leucovorin 928Irinotecan 815Bevacizumab 803Cisplatin 666Radiotherapy 535Cetuximab 469pembrolizumab 428Paclitaxel 389Nivolumab 336130-nm albumin-bound paclitaxel 322Drug Therapy 314Docetaxel 286S 1 (combination) 273Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 209Surgical Procedures, Operative 203tislelizumab 202Radiosurgery 202lenvatinib 201apatinib 198Carboplatin 186Magnetic Resonance Spectroscopy 181regorafenib 180

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Disulfiram × Gastrointestinal × Clear all
NCT02671890 2025-01-07

Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer

Mayo Clinic

Phase 1 Terminated
16 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03714555 2023-10-18

Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine

HonorHealth Research Institute

Phase 2 Terminated
1 enrolled 7 charts
Gastrointestinal

Pancreatic Neoplasms

NCT05667415 2022-12-28

Treatment of Advance Gastric Cancer With Disulfiram

First People's Hospital of Hangzhou

Phase NA Not yet recruiting
40 enrolled
Gastrointestinal

Chemotherapy;Advanced Gastric Cancer;Cisplatin;Disulfiram

Data powered by HemOnc (CC BY 4.0) Colophon ⚡